NCT05973305View on ClinicalTrials.gov

Comparative Study of Dorzol Eye Drops, 20 mg/ml Versus Trusopt® Eye Drops, 20 mg/ml

PHASE3CompletedINTERVENTIONAL

Enrollment

118

Participants

Timeline

Start Date

April 5, 2017

Primary Completion Date

April 5, 2017

Study Completion Date

September 1, 2018

Conditions

Primary Open Angle Glaucoma of Both Eyes

Interventions

DRUG

Dorzol 20 mg/ml

dosing schedule t.i.d.

DRUG

Trusopt 20 mg/ml

dosing schedule t.i.d.

Trial Locations (1)

Unknown

State autonomous healthcare institution 'Republican Clinical Ophthalmological Hospital of the Ministry of Health of the Republic of Tatarstan', Kazan'

All Listed Sponsors

lead

Jadran Galenski laboratorij d.d.

INDUSTRY

NCT05973305 - Comparative Study of Dorzol Eye Drops, 20 mg/ml Versus Trusopt® Eye Drops, 20 mg/ml | Biotech Hunter | Biotech Hunter